About Us
- African biomanufacturer of “best-in-class” molecular biology enzymes.
- Artificial Intelligence (AI) platform with proprietary machine learning algorithms for development of “best-in-class” enzymes and kits.
- Highly skilled team of scientists that help clients increase their productivity.
We use our proprietary technology for large scale biomanufacturing of our enzymes and assays.
CapeBio™ Technologies Pty (Ltd) (CapeBio™) with registration number: 2018/505984/07 is a South African biotechnology company that specializes in biomanufacturing of molecular biology enzyme technologies. These products are sourced from rich South African indigenous biodiversity hotspots.
Our enzymes are key drivers and components for molecular diagnostics assays.
We have experience in developing molecular, biotechnology and bioinformatics technologies and their applications.
CapeBio™ is a 100% BBBEE company.
Countries using our products
Expert Staff
Vision
We create excellent innovations that improve the quality of life in Africa and beyond.
Mission
To develop “best-in-class “life science research enzymes, assays and kits discovered from the rich African indigenous microbial diversity.
Our History
CapeBio™ Initiative
CapeBio™ Initiative is conceptualized and initiated at Council for Scientific and Industrial Research (CSIR) – with the support from Department of Science and Innovation (DSI).
2015CapeBio™ Initiative
CapeExpress™ DNA ligase
The first flagship product (CapeExpress™ DNA ligase) is launched for market testing. The product is distributed to researchers across South Africa for evaluation and feedback. We also trademarked in different territories.
2016CapeExpress™ DNA ligase
CapeSprint™ Taq DNA Polymerase
The second flagship product (CapeSprint™ Taq DNA polymerase) enters a market testing phase. It is distributed to the researchers across South Africa, Southern, Western and Eastern Africa.
2017CapeSprint™ Taq DNA Polymerase
CapeHi-Fidelity™ and Pty (Ltd) Registered
The third product (CapeHi-Fidelity™ Pfu DNA polymerase) enters the market testing phase and distributed to researchers for evaluations and feedback. And CapeBio™ Technologies (Pty) Ltd is officially registered as a private entity.
2018CapeHi-Fidelity™ and Pty (Ltd) Registered
Funding, Partnerships and Awards
We raised funding with E2 Investments and officially launched the products in the market. While winning 3rd Prize Award at the Africa Start-up Gate Summit in Tunisia and 1st Prize Award in partnership with ARC at the South African Innovation Bridge sponsored by Department of Science and Innovation, Technology Innovation Agency, SEDA and KISCH IP.
2019Funding, Partnerships and Awards
COVID-19 RT-qPCR test kit
CapeBio™ develops COVID-19 RT-qPCR test kit and associated reagents.
2020COVID-19 RT-qPCR test kit
Proprietary AI Platform Development Launch
CapeBio™ develops and launches its proprietary AI and machine learning platform for development of "best-in-class" biomolecules for wide range of life science industrial applications.
2021Proprietary AI Platform Development Launch
Why Choose Us
We create excellent innovations that improve the quality of life in Africa and beyond.
High Quality Products
Optimized Products
Customized Solutions
Scale-Up Manufacturing
Subscribe To Our Newsletter
Stay in touch with us to get latest news and special offers.
Address
CapeBio™ Technologies (Pty) Ltd Unit 2 Parkside Office Park, 86 Oak Avenue, Highveld Technopark, Centurion, 0157
Call Us
General: +27 (0) 12 665 2600
Sales: +27 (0) 12 665 0422
Email Us
General: info@capebiosa.com
Sales: sales@capebiosa.com
Support: techsupport@capebiosa.com